Form 4 for BLFS BIOLIFE SOLUTIONS INC
Accepted 2022-02-14 00:00:00 ET · period of report 2022-02-10 · accession 0001437749-22-003346 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-02-14 | 2022-02-10 | BLFS | Berard Todd | CMO | S - Sale | $29.38 | -254 | 76.9K | -0.3% | -$7,463 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-02-10 | S | D | 254 | $29.38 | 76,893 | D | — | — |